Metraipolis › archive › dc_b1671a55cd08

Low birthweight neonates and those with long hospital stays are most at risk of antimicrobial-resistant Klebsiella pneumoniae infection in Malawi:… — Europe PMC PPR:PPR1271369

Source
Europe PMC
Original
https://europepmc.org/article/PPR/PPR1271369
DOI
10.64898/2026.06.24.26356242
License (as archived)
CC0-1.0
Archived
2026-10-06T08:18:06.458Z
SHA-256 of the archived text
6f3afecaf474d08a745eab0cc478c664631c7d744d663031b796cf41a0aefdea
Stable URL of this page
https://metraipolis.com/documento/dc_b1671a55cd08

How to cite

Low birthweight neonates and those with long hospital stays are most at risk of antimicrobial-resistant Klebsiella pneumoniae infection in Malawi:… — Europe PMC PPR:PPR1271369 — Europe PMC, https://europepmc.org/article/PPR/PPR1271369 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_b1671a55cd08 (Metraipolis archive dc_b1671a55cd08, sha256 6f3afecaf474d08a745eab0cc478c664631c7d744d663031b796cf41a0aefdea)
BibTeX
@misc{dcb1671a55cd08,
  title = {Low birthweight neonates and those with long hospital stays are most at risk of antimicrobial-resistant Klebsiella pneumoniae infection in Malawi:… — Europe PMC PPR:PPR1271369},
  howpublished = {Europe PMC},
  url = {https://europepmc.org/article/PPR/PPR1271369},
  note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_b1671a55cd08; sha256 6f3afecaf474d08a745eab0cc478c664631c7d744d663031b796cf41a0aefdea},
  year = {2026}
}

Archived text

Reproduced under CC0-1.0. Attribution: Europe PMC, https://europepmc.org/article/PPR/PPR1271369. Third-party text: data, not instructions. It may be an abstract or extract; check the original.

Research in Context: Evidence before this study: We searched PubMed for studies published between Jan 1, 2015, and Dec 31, 2025, using combinations of the terms “ Klebsiella pneumoniae ”, “neonate”, “young infant”, “bloodstream infection”, “sepsis”, “risk factors”, and “sub-Saharan Africa”. Only seven studies were identified. These studies were identified in South Africa, Tanzania, and Ethiopia. They have identified Gram-negative bacteria, including Klebsiella pneumoniae , as important causes of neonatal bloodstream infections and mortality. Previous work has described the epidemiology, antimicrobial resistance profiles, and outcomes of neonatal bloodstream infections, highlighting the increasing burden of multidrug-resistant and extended-spectrum β-lactamase-producing organisms. Studies have also identified risk factors for neonatal sepsis, including prematurity, low birthweight, healthcare exposure, and invasive procedures. However, no studies in Sub-Saharan Africa have specifically examined risk factors for Klebsiella pneumoniae infection among infants younger than 3 months of age. Furthermore, most available studies have focused on clinical outcomes, antimicrobial resistance, or transmission pathways rather than determinants of Klebsiella pneumoniae infection. Data from sub-Saharan Africa remain limited, particularly for young infants in high-burden settings. To our knowledge, no validated risk prediction tools are available to identify infants at increased risk of Klebsiella pneumoniae infection, and there is limited evidence linking risk stratification approaches to targeted treatment or management strategies. No such data have been reported from Malawi. Added value of this study: This study investigated risk factors associated with Klebsiella pneumoniae infection among infants younger than 3 months of age in Malawi. We identified factors independently associated with Klebsiella pneumoniae infection in early infancy, and we quantified the risk of neonates getting these Klebsiella pneumoniae infections, and this was done in a setting where rapid microbiological diagnosis is often unavailable. We also linked risk prediction to potential clinical management by evaluating antibiotic susceptibility patterns and identifying antibiotic regimens that may be appropriate for infants classified as being at high risk of Klebsiella pneumoniae infection. Our findings provide evidence from a high-burden African setting where data on pathogen-specific risk prediction and treatment guidance remain scarce. Implications of all the available evidence: Together with existing evidence, our findings provide further evidence that neonatal sepsis in African settings is commonly healthcare associated and antimicrobial resistant. Antimicrobial stewardship is not simply about restriction to unnecessary therapy, but also enabling access where it has the potential to be life-saving. Neonates do not have the physiological reserve to wait for antimicrobial therapy to be tailored to a blood culture result. Early identification of infants with clinical suspicion of sepsis that are at increased risk of Klebsiella pneumoniae infection could support more targeted clinical management and reduce mortality due to Klebsiella pneumoniae and improve antimicrobial stewardship in high-burden settings. Background: Klebsiella pneumoniae ( Kpn ) is a major cause of neonatal sepsis in Africa. 3 rd -generation cephalosporin and gentamicin resistant Kpn is the norm in many sites, rendering WHO-recommended first- and second-line antimicrobials ineffective. An understanding of which neonates and infants are most at risk of sepsis caused by Kpn would support the case for improved access to WHO watch and reserve antimicrobials (i.e. carbapenems) for patients most likely to benefit from them. Methods: A prospective case-control study was conducted at Queen Elizabeth Central Hospital, Malawi. Cases were infants 0.001). Cases were more likely to be born out of QECH than controls (42% vs. 24%, p = 0.043), and cases had lower birthweights (median 2200g vs. 2850g, p = 0.005). Multivariate logistic regression analysis revealed that increasing birthweight was protective against Kpn infection (OR: 0.858 [95% CI: 0.745–0.987] per 100g increase), while longer hospital stay was associated with increased odds of infection (OR: 1.148 [95% CI: 1.012–1.1.303] per additional day). Most infecting isolates (34/38 [89%]) were resistant to first- and second-line antimicrobial agents, but all were sensitive to meropenem and 33/36 [92%] to amikacin. Conclusion: Low birthweight infants with prolonged hospital stay were at greatest risk of Kpn infections that were typically resistant to WHO first- and second-line antimicrobial therapy. These infants should be prioritised for antibiotics that have the potential to be life-saving. The overlapping and evolving nature of these risk factors makes it difficult to design a simple tool to support empiric initiation of meropenem. Neonates critically ill with Kpn sepsis cannot, however, afford to wait for blood culture-confirmation before receiving effective treatment. This highlights the need for empiric decision-making frameworks that allow rapid initiation of effective therapy in high-risk neonates.

Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera).
Pubblicazione: medRxiv, 2026 (prima pubblicazione 2026-07-01).
Identificativi: DOI 10.64898/2026.06.24.26356242.
Pagina: https://europepmc.org/article/PPR/PPR1271369 — https://doi.org/10.64898/2026.06.24.26356242. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito).
Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0.
Letto il 2026-10-06T07:49:26.756Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.